MC
Mayo Clinic
Rochester, Minnesota, United StatesFounded 1985
Mayo Clinic Ventures focuses on commercializing its own discoveries and investing in companies aligned with its strategic interests in healthcare innovation, particularly in diagnostics, AI digital health, tech-enabled therapeutics, biotechnology, and medical technology. Their strategy involves creating and funding companies based on Mayo Clinic intellectual property, co-investing in promising startups, and building new ventures, often in response to declining government research funding.
64% of their portfolio is in Healthcare. Average disclosed round size is $55.2M (across 32 rounds with reported amounts).
Portfolio
33
Fund Size
$15.3B
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 WHOOP | Series G | $575M | Mar 2026 |
 Lin Health | Series A | $11M | Dec 2025 |
 MediView XR, Inc. | Series A | $24M | Oct 2025 |
 Myosin Therapeutics Inc. | Seed | $3M | Feb 2025 |
 Aignostics | Series B | $34M | Oct 2024 |
 Endogenex | Series C | $88M | Jun 2024 |
 Collaborative Robotics | Series B | $100M | Apr 2024 |
| BBasys.ai | Seed | $2.4M | Aug 2023 |
| BBasys.ai | Pre-Seed | $2.4M | Aug 2023 |
| Collaborative Robotics | Series A | $30M | Jul 2023 |
 Medivis | Series A | $20M | Jun 2023 |
 Cadence Neuroscience | Series B | $26M | May 2023 |
| MediView XR, Inc. | Series A | $15M | May 2023 |
 Senda Biosciences | Series C | $123M | Aug 2022 |
 Diagnostic Robotics | Series B | $45M | Jul 2022 |
| LLisa Health | Seed | $2.5M | Jul 2022 |
 Theator | Series A | $24M | Jul 2022 |
 Ordr | Series C | $40M | Jun 2022 |
 Vyriad, Inc. | Series B | $29.5M | May 2022 |
| MMedically Home | Growth | $110M | Jan 2022 |
| TTripleBlind | Series A | $24M | Oct 2021 |
| Senda Biosciences | Series B | $55M | Jun 2021 |
 Helix | Series C | $50M | Jun 2021 |
| MMedically Home | Unknown | — | May 2021 |
 nference | Series C | $60M | Dec 2020 |
Page 1 of 2
Top Co-Investors
General Catalyst3 shared
Sequoia Capital3 shared
Two Lanterns2 shared
NTTVC2 shared
Flagship Pioneering2 shared
Alexandria Venture Investments2 shared
Kaiser Permanente Ventures2 shared
Cleveland Clinic2 shared
JobsOhio2 shared
Khosla Ventures2 shared
Neo2 shared
1984 Ventures2 shared
MVP Ventures2 shared
Calibrate Ventures2 shared
Qatar Investment Authority2 shared
Eli Lilly1 shared
Catalio Capital Management1 shared
The Production Board1 shared
Mountain Group Partners1 shared
OCA Ventures1 shared
Last updated: 12 April 2026